130 related articles for article (PubMed ID: 38834381)
1. Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation.
Zanetto A; Campello E; Spiezia L; Gavasso S; Bulato C; Burra P; Russo FP; Senzolo M; Simioni P
Dig Liver Dis; 2024 Jun; ():. PubMed ID: 38834381
[TBL] [Abstract][Full Text] [Related]
2. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
3. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
[TBL] [Abstract][Full Text] [Related]
4. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
[TBL] [Abstract][Full Text] [Related]
6. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
7. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.
Wang T; Tan W; Wang X; Zheng X; Huang Y; Li B; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Yan H; Zheng Y; Zhang W; Yin S; Gu W; Zhang Y; Dong F; Wei J; Deng G; Xiang X; Zhou Y; Hou Y; Zhang Q; Xiong S; Liu J; Long L; Chen R; Chen J; Jiang X; Luo S; Chen Y; Jiang C; Zhao J; Ji L; Mei X; Li J; Li T; Zheng R; Zhou X; Ren H; Shi Y; Li H;
JHEP Rep; 2022 Oct; 4(10):100529. PubMed ID: 36052222
[TBL] [Abstract][Full Text] [Related]
8. Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome.
Zanetto A; Toffanin S; Campello E; Radu CM; Gavasso S; Burra P; Russo FP; Senzolo M; Simioni P
Dig Liver Dis; 2024 Mar; ():. PubMed ID: 38553338
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death.
Zanetto A; Campello E; Bulato C; Gavasso S; Farinati F; Russo FP; Tormene D; Burra P; Senzolo M; Simioni P
J Hepatol; 2022 Sep; 77(3):660-669. PubMed ID: 35364225
[TBL] [Abstract][Full Text] [Related]
11. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
12. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
14. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis.
Weber A; Krebs S; Lenhardt C; Wagenpfeil S; Schmid RM; Schulte-Frohlinde E
Hepatol Res; 2009 Sep; 39(9):882-7. PubMed ID: 19619258
[TBL] [Abstract][Full Text] [Related]
15. Portal vein thrombosis associates with high platelet-fibrin clot strength and platelet activation in decompensated cirrhosis: A retrospective study.
Quan X; Ye X; Qian S; Wei B; Tong H; Wang Z; Tai Y; Guo X; Gao J; Wu H
Dig Liver Dis; 2023 May; 55(5):629-636. PubMed ID: 36280436
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of thrombin generation assay in factor XI deficiency.
Kasonga F; Feugray G; Chamouni P; Barbay V; Fresel M; Chretien MH; Brunel S; Le Cam Duchez V; Billoir P
Clin Chim Acta; 2021 Dec; 523():348-354. PubMed ID: 34670127
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco A; Laudani C; Spagnolo M; Agnello F; Faro DC; Finocchiaro S; Legnazzi M; Mauro MS; Mazzone PM; Occhipinti G; Rochira C; Scalia L; Capodanno D
Circulation; 2023 Mar; 147(11):897-913. PubMed ID: 36913497
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
19. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
20. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]